|
|
Volumn 15, Issue 13, 2016, Pages 1295-
|
|
Towards greater transparency in clinical trial reporting
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLINICAL RESEARCH;
CLINICAL TRIAL (TOPIC);
EDITORIAL;
FEASIBILITY STUDY;
FOOD AND DRUG ADMINISTRATION;
FUNDING;
HEALTH SERVICE;
HUMAN;
MEDICAL INFORMATION SYSTEM;
NATIONAL HEALTH ORGANIZATION;
NEUROLOGIST;
NEUROLOGY;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESEARCH ETHICS;
SYSTEMATIC REVIEW (TOPIC);
UNITED STATES;
CONFIDENTIALITY;
INTERPERSONAL COMMUNICATION;
LEGISLATION AND JURISPRUDENCE;
CLINICAL TRIALS AS TOPIC;
CONFIDENTIALITY;
DISCLOSURE;
HUMANS;
|
|
EID: 84994423037
PISSN: 14744422
EISSN: 14744465
Source Type: Journal
DOI: 10.1016/S1474-4422(16)30296-4 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|